ArticleJournal of neuromuscular diseases2023

Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy.

Francesco Muntoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.